Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Unlocking the Potential of Sub-Saharan Africa in Globalized Cancer Clinical Trials: A Perspective From the 2024 AORTIC-ASCO Stakeholder Meeting.
Journal: JCO global oncology
Published: July 22, 2026
Pragmatic Clinical Trial Assessing Response to Neoadjuvant Docetaxel and Trastuzumab in Nigerian Women With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer (ARETTA).
Journal: JCO global oncology
Published: May 29, 2026
Leveraging HIV prevention programs for breast cancer interventions: A survey of women stakeholders in the informal work sector in Nigeria.
Journal: Women's health (London, England)
Published: November 30, 2025
Inavolisib Therapy in Advanced Breast Cancer.
Journal: The New England journal of medicine
Published: January 15, 2025
Global Equity in Clinical Trials: An ASCO Policy Statement.
Journal: JCO global oncology
Published: March 14, 2024
COVID-19-Related Treatment Cancellations and Oncology Patients' Psychological Health in Nigeria.
Journal: Clinical medicine & research
Published: May 23, 2023
Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics.
Journal: JCO global oncology
Published: March 15, 2023
Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer.
Journal: JAMA oncology
Published: February 16, 2023
Cancer Clinical Trials in Africa-An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials.
Journal: JCO global oncology
Published: September 10, 2021
Emerging Use of Public-Private Partnerships in Public Radiotherapy Facilities in Nigeria.
Journal: JCO global oncology
Published: August 05, 2021
Racial disparities in survival outcomes among breast cancer patients by molecular subtypes.
Journal: Breast cancer research and treatment
Published: August 17, 2020
ARETTA: Assessing Response to Neoadjuvant Taxotere and Subcutaneous Trastuzumab in Nigerian Women With HER2-Positive Breast Cancer: A Study Protocol.
Journal: JCO global oncology
Published: July 07, 2020
Last Updated: 09/26/2026